Anti-Her2 / ERBB2 Antibody

Price:
Size:
Number:

Anti-Her2 / ERBB2 Antibody (Rabbit Monoclonal 抗体) の製品情報

製品名
Anti-Her2 / ERBB2 Antibody
検証済のアプリケーション
ELISA
交差反応
Reacts with: Rat
特異性
Rat Her2 / ERBB2
Has cross-reactivity in ELISA with
Mouse Erbb2
No cross-reactivity in ELISA with
Human Erbb2
Rat ERBB3
Rat ERBB4
Human EGFR
免疫原
Recombinant Rat HER2 / ErbB2 protein (Catalog#80079-R08H)
調製
This antibody was obtained from a rabbit immunized with purified, recombinant Rat HER2 / ErbB2 (Catalog#80079-R08H; AAH61863.1; Met4-Thr656).
ソース
Monoclonal Rabbit IgG Clone #006
精製
Protein A
緩衝液
0.2 μm filtered solution in PBS
標識物
Unconjugated
状態
Liquid
配送方法
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
保存条件
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

Anti-Her2 / ERBB2 Antibody (Rabbit Monoclonal 抗体) 検証済のアプリケーション

アプリケーション 推奨希釈率/用量
ELISA 1:5000-1:10000
Please Note: Optimal concentrations/dilutions should be determined by the end user.

Her2 / ERBB2 背景情報

Epidermal growth factor receptor 2 (HER2), also known as ErbB2, NEU, and CD34, is a type I membrane glycoprotein, and belongs to the epidermal growth factor (EGF) receptor family. HER2 protein cannot bind growth factors due to the lacking of ligand binding domain of its own and autoinhibited constitutively. However, HER2 forms a heterodimer with other ligand-bound EGF receptor family members, therefore stabilizes ligand binding and enhances kinase-mediated activation of downstream molecules. HER2 plays a key role in development, cell proliferation and differentiation. HER2 gene has been reported to associate with malignancy and a poor prognosis in numerous carcinomas, including breast, prostate, ovarian, lung cancers and so on.
完全な名称
erb-b2 receptor tyrosine kinase 2
参考文献
  • Krawczyk N, et al. (2009) HER2 status on persistent disseminated tumor cells after adjuvant therapy may differ from initial HER2 status on primary tumor. Anticancer Res. 29(10): 4019-24.
カートに追加しました カートに追加しませんでした カートを更新しています。少々お待ちください